Connect with others who understand.

Sign up Log in
Resources
About MyVitiligoTeam
Powered By
SPONSORED IN PART BY INCYTE ?

4 Vitiligo Advances: How Research Improves Treatment

Posted on October 31, 2024

Enter Cell 2 Content Here...

Enter Cell 3 Content Here...

Enter Cell 4 Content Here...

Enter Cell 5 Content Here...

Enter Cell 6 Content Here...

Clinical research helps us learn more about new potential treatments for conditions like vitiligo.1 In the past five to 10 years, researchers have found new ways to help with vitiligo symptoms. However, new treatment options are needed to help more people with vitiligo.2 Researchers test the safety and efficacy of investigational treatments through clinical trials.1

Read on to learn about four ways research has helped expand treatment options for vitiligo.

1. JAK Inhibitors

Recently there has been more research into drugs called biologics and small molecule inhibitors to treat autoimmune conditions.2,3 For vitiligo, one focus is on small molecule inhibitors that target Janus kinase (JAK) pathways.2

In 2022, the U.S. Food and Drug Administration (FDA) approved a topical JAK inhibitor cream for people 12 and older with nonsegmental vitiligo. It’s the first treatment approved to help restore skin color, or pigment, in people with vitiligo.4

Researchers are also studying several different oral JAK inhibitors to see if they can help treat vitiligo.2 These drugs are in clinical trials to test their safety and effectiveness. Research on JAK inhibitors aims to develop more treatments that help improve symptoms of vitiligo.2

One type of surgery for vitiligo is a cell transplant.

Enter Cell 2 Content Here...

Enter Cell 3 Content Here...

Enter Cell 4 Content Here...

Enter Cell 5 Content Here...

Enter Cell 6 Content Here...

2. Surgical Devices

Another advancement in vitiligo treatment is in surgical devices. Surgery can help restore skin color. However, it’s recommended only in some cases, like when topical treatments and phototherapies haven’t worked or if your vitiligo is stable and not active, meaning existing patches haven’t grown or new ones haven’t emerged in the last 12 months.5 One type of surgery is a cell transplant, in which a surgeon moves healthy skin cells to patches of skin with vitiligo.5

In 2023, the FDA approved a surgical device to restore skin color in people with stable vitiligo.6 This device uses a laser to collect and transplant healthy skin cells onto areas of skin with vitiligo.6

Surgery can help restore skin color, usually after other treatments have not worked.

Enter Cell 2 Content Here...

Enter Cell 3 Content Here...

Enter Cell 4 Content Here...

Enter Cell 5 Content Here...

Enter Cell 6 Content Here...

3. Combination Therapy

Health care providers may suggest using multiple treatments together, called combination therapy. Sometimes, medications are used with light therapy to restore skin color.2,5

Recent research has looked into the safety and efficacy of combining different vitiligo treatments, like surgery with light therapy. This research helps improve treatment guidelines for vitiligo.2,7,8

Recent research has looked into the safety and effectiveness of combining different vitiligo treatments, like surgery with light therapy.

Enter Cell 2 Content Here...

Enter Cell 3 Content Here...

Enter Cell 4 Content Here...

Enter Cell 5 Content Here...

Enter Cell 6 Content Here...

4. Treatment Options on the Horizon

Researchers are also exploring other ways to treat vitiligo. Some are looking at drugs that target microRNAs (miRNAs), which may be involved in vitiligo development.9 MiRNAs can affect the genes in pigment-producing cells.9

There’s also research on treatments targeting regulatory T cells (Tregs), which are immune system cells. Scientists have identified Tregs as a factor involved in the development of vitiligo. Some studies are exploring the use of treatments that activate Tregs and how they affect vitiligo symptoms.2

Another area of research is monoclonal antibodies, which target substances in the immune system that might cause vitiligo.2

Communicate With Your Health Care Provider

Talk to your dermatologist or another health care provider about your vitiligo treatment options. You can also ask about joining clinical trials. Participating in clinical trials can help bring more treatment options in the future.

Talk With Others Who Understand

MyVitiligoTeam is the social network for people with vitiligo and their loved ones. Here, over 13,000 members come together to ask questions, offer support and advice, and meet others who understand life with vitiligo.

Are you curious about how research may lead to vitiligo treatment options? Share your thoughts in the comments below or by posting on MyVitiligoTeam.

References
  1. NIH clinical research trials and you: the basics. National Institutes of Health. Updated October 3, 2022. Accessed May 6, 2024. https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics
  2. Seong SH, Oh SH. Up-and-coming drugs for the treatment of vitiligo. Ann Dermatol. 2024;36(4):197-208. doi:10.5021/ad.24.038
  3. Understanding biologic and biosimilar drugs. American Cancer Society Cancer Action Network. July 27, 2018. Accessed May 6, 2024. https://www.fightcancer.org/policy-resources/understanding-biologic-and-biosimilar-drugs
  4. FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older. U.S. Food and Drug Administration. July 19, 2022. Accessed May 6, 2024. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-topical-treatment-addressing-repigmentation-vitiligo-patients-aged-12-and-older
  5. Ludmann, P. Vitiligo: diagnosis and treatment. American Academy of Dermatology. Updated May 25, 2023. Accessed May 6, 2024. https://www.aad.org/public/diseases/a-z/vitiligo-treatment
  6. RECELL autologous cell harvesting device (model number: AVRL0102). U.S. Food and Drug Administration. December 14, 2023. Accessed May 6, 2024. https://www.fda.gov/vaccines-blood-biologics/approved-blood-products/recell-autologous-cell-harvesting-device-model-number-avrl0102
  7. Liu J, Chen Q. Clinical effect of stem cell transplantation combined with 308-nm excimer laser therapy for 56 cases of vitiligo. J Cosmet Dermatol. 2023; 22(12):3276-3281. doi:10.1111/jocd.15833
  8. Zhu B, Liu C, Zhang L, Wang J, Chen M, Wei Y. Comparison of NB-UVB combination therapy regimens for vitiligo: a systematic review and network meta-analysis. J Cosmet Dermatol. 2023;22(3):1083-1098. doi:10.1111/jocd.15534
  9. Li W, Pang Y, He Q, et al. Exosome-derived microRNAs: emerging players in vitiligo. Front Immunol. 2024;15:1419660. doi:10.3389/fimmu.2024

Posted on October 31, 2024
All updates must be accompanied by text or a picture.

We'd love to hear from you! Please share your name and email to post and read comments.

You'll also get the latest articles directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
All updates must be accompanied by text or a picture.

Subscribe now to ask your question, get answers, and stay up to date on the latest articles.

Get updates directly to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service.
Privacy Policy
Elizabeth Wartella, M.P.H. is an Editor at MyHealthTeam. She holds a Master's in Public Health from Columbia University and is passionate about spreading accurate, evidence-based health information. Learn more about her here.

Thank you for subscribing!

Become a member to get even more: